Global Chickenpox (Varicella) Vaccine Market Insights and Forecast to 2028

Report ID: 1802968 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Chickenpox (Varicella) Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Chickenpox (Varicella) Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Monovalent Vaccine
        1.2.3 Combination Vaccine
    1.3 Market by Application
        1.3.1 Global Chickenpox (Varicella) Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Kids Injection
        1.3.3 Adults Injection
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Chickenpox (Varicella) Vaccine Sales Estimates and Forecasts 2017-2028
    2.2 Global Chickenpox (Varicella) Vaccine Revenue Estimates and Forecasts 2017-2028
    2.3 Global Chickenpox (Varicella) Vaccine Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Chickenpox (Varicella) Vaccine Sales by Region
        2.4.1 Global Chickenpox (Varicella) Vaccine Sales by Region (2017-2022)
        2.4.2 Global Sales Chickenpox (Varicella) Vaccine by Region (2023-2028)
    2.5 Global Chickenpox (Varicella) Vaccine Revenue by Region
        2.5.1 Global Chickenpox (Varicella) Vaccine Revenue by Region (2017-2022)
        2.5.2 Global Chickenpox (Varicella) Vaccine Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Chickenpox (Varicella) Vaccine Sales by Manufacturers
        3.1.1 Global Top Chickenpox (Varicella) Vaccine Manufacturers by Sales (2017-2022)
        3.1.2 Global Chickenpox (Varicella) Vaccine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Chickenpox (Varicella) Vaccine in 2021
    3.2 Global Chickenpox (Varicella) Vaccine Revenue by Manufacturers
        3.2.1 Global Chickenpox (Varicella) Vaccine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Chickenpox (Varicella) Vaccine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Chickenpox (Varicella) Vaccine Revenue in 2021
    3.3 Global Chickenpox (Varicella) Vaccine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Chickenpox (Varicella) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Chickenpox (Varicella) Vaccine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Chickenpox (Varicella) Vaccine Sales by Type
        4.1.1 Global Chickenpox (Varicella) Vaccine Historical Sales by Type (2017-2022)
        4.1.2 Global Chickenpox (Varicella) Vaccine Forecasted Sales by Type (2023-2028)
        4.1.3 Global Chickenpox (Varicella) Vaccine Sales Market Share by Type (2017-2028)
    4.2 Global Chickenpox (Varicella) Vaccine Revenue by Type
        4.2.1 Global Chickenpox (Varicella) Vaccine Historical Revenue by Type (2017-2022)
        4.2.2 Global Chickenpox (Varicella) Vaccine Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2017-2028)
    4.3 Global Chickenpox (Varicella) Vaccine Price by Type
        4.3.1 Global Chickenpox (Varicella) Vaccine Price by Type (2017-2022)
        4.3.2 Global Chickenpox (Varicella) Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Chickenpox (Varicella) Vaccine Sales by Application
        5.1.1 Global Chickenpox (Varicella) Vaccine Historical Sales by Application (2017-2022)
        5.1.2 Global Chickenpox (Varicella) Vaccine Forecasted Sales by Application (2023-2028)
        5.1.3 Global Chickenpox (Varicella) Vaccine Sales Market Share by Application (2017-2028)
    5.2 Global Chickenpox (Varicella) Vaccine Revenue by Application
        5.2.1 Global Chickenpox (Varicella) Vaccine Historical Revenue by Application (2017-2022)
        5.2.2 Global Chickenpox (Varicella) Vaccine Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2017-2028)
    5.3 Global Chickenpox (Varicella) Vaccine Price by Application
        5.3.1 Global Chickenpox (Varicella) Vaccine Price by Application (2017-2022)
        5.3.2 Global Chickenpox (Varicella) Vaccine Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Chickenpox (Varicella) Vaccine Market Size by Type
        6.1.1 North America Chickenpox (Varicella) Vaccine Sales by Type (2017-2028)
        6.1.2 North America Chickenpox (Varicella) Vaccine Revenue by Type (2017-2028)
    6.2 North America Chickenpox (Varicella) Vaccine Market Size by Application
        6.2.1 North America Chickenpox (Varicella) Vaccine Sales by Application (2017-2028)
        6.2.2 North America Chickenpox (Varicella) Vaccine Revenue by Application (2017-2028)
    6.3 North America Chickenpox (Varicella) Vaccine Market Size by Country
        6.3.1 North America Chickenpox (Varicella) Vaccine Sales by Country (2017-2028)
        6.3.2 North America Chickenpox (Varicella) Vaccine Revenue by Country (2017-2028)
        6.3.3 the United States
        6.3.4 Canada
7 Europe
    7.1 Europe Chickenpox (Varicella) Vaccine Market Size by Type
        7.1.1 Europe Chickenpox (Varicella) Vaccine Sales by Type (2017-2028)
        7.1.2 Europe Chickenpox (Varicella) Vaccine Revenue by Type (2017-2028)
    7.2 Europe Chickenpox (Varicella) Vaccine Market Size by Application
        7.2.1 Europe Chickenpox (Varicella) Vaccine Sales by Application (2017-2028)
        7.2.2 Europe Chickenpox (Varicella) Vaccine Revenue by Application (2017-2028)
    7.3 Europe Chickenpox (Varicella) Vaccine Market Size by Country
        7.3.1 Europe Chickenpox (Varicella) Vaccine Sales by Country (2017-2028)
        7.3.2 Europe Chickenpox (Varicella) Vaccine Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 UK
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Chickenpox (Varicella) Vaccine Market Size by Type
        8.1.1 Asia Pacific Chickenpox (Varicella) Vaccine Sales by Type (2017-2028)
        8.1.2 Asia Pacific Chickenpox (Varicella) Vaccine Revenue by Type (2017-2028)
    8.2 Asia Pacific Chickenpox (Varicella) Vaccine Market Size by Application
        8.2.1 Asia Pacific Chickenpox (Varicella) Vaccine Sales by Application (2017-2028)
        8.2.2 Asia Pacific Chickenpox (Varicella) Vaccine Revenue by Application (2017-2028)
    8.3 Asia Pacific Chickenpox (Varicella) Vaccine Market Size by Region
        8.3.1 Asia Pacific Chickenpox (Varicella) Vaccine Sales by Region (2017-2028)
        8.3.2 Asia Pacific Chickenpox (Varicella) Vaccine Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Chickenpox (Varicella) Vaccine Market Size by Type
        9.1.1 Latin America Chickenpox (Varicella) Vaccine Sales by Type (2017-2028)
        9.1.2 Latin America Chickenpox (Varicella) Vaccine Revenue by Type (2017-2028)
    9.2 Latin America Chickenpox (Varicella) Vaccine Market Size by Application
        9.2.1 Latin America Chickenpox (Varicella) Vaccine Sales by Application (2017-2028)
        9.2.2 Latin America Chickenpox (Varicella) Vaccine Revenue by Application (2017-2028)
    9.3 Latin America Chickenpox (Varicella) Vaccine Market Size by Country
        9.3.1 Latin America Chickenpox (Varicella) Vaccine Sales by Country (2017-2028)
        9.3.2 Latin America Chickenpox (Varicella) Vaccine Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Chickenpox (Varicella) Vaccine Market Size by Type
        10.1.1 Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Chickenpox (Varicella) Vaccine Revenue by Type (2017-2028)
    10.2 Middle East and Africa Chickenpox (Varicella) Vaccine Market Size by Application
        10.2.1 Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Chickenpox (Varicella) Vaccine Revenue by Application (2017-2028)
    10.3 Middle East and Africa Chickenpox (Varicella) Vaccine Market Size by Country
        10.3.1 Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Chickenpox (Varicella) Vaccine Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Merck & Co.
        11.1.1 Merck & Co. Corporation Information
        11.1.2 Merck & Co. Overview
        11.1.3 Merck & Co. Chickenpox (Varicella) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Merck & Co. Chickenpox (Varicella) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Merck & Co. Recent Developments
    11.2 Sanofi Pasteur
        11.2.1 Sanofi Pasteur Corporation Information
        11.2.2 Sanofi Pasteur Overview
        11.2.3 Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Sanofi Pasteur Chickenpox (Varicella) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Sanofi Pasteur Recent Developments
    11.3 GSK
        11.3.1 GSK Corporation Information
        11.3.2 GSK Overview
        11.3.3 GSK Chickenpox (Varicella) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 GSK Chickenpox (Varicella) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 GSK Recent Developments
    11.4 Shanghai Institute
        11.4.1 Shanghai Institute Corporation Information
        11.4.2 Shanghai Institute Overview
        11.4.3 Shanghai Institute Chickenpox (Varicella) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Shanghai Institute Chickenpox (Varicella) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Shanghai Institute Recent Developments
    11.5 BCHT
        11.5.1 BCHT Corporation Information
        11.5.2 BCHT Overview
        11.5.3 BCHT Chickenpox (Varicella) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 BCHT Chickenpox (Varicella) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 BCHT Recent Developments
    11.6 Changsheng
        11.6.1 Changsheng Corporation Information
        11.6.2 Changsheng Overview
        11.6.3 Changsheng Chickenpox (Varicella) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Changsheng Chickenpox (Varicella) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Changsheng Recent Developments
    11.7 Keygen
        11.7.1 Keygen Corporation Information
        11.7.2 Keygen Overview
        11.7.3 Keygen Chickenpox (Varicella) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Keygen Chickenpox (Varicella) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Keygen Recent Developments
    11.8 Green Cross
        11.8.1 Green Cross Corporation Information
        11.8.2 Green Cross Overview
        11.8.3 Green Cross Chickenpox (Varicella) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Green Cross Chickenpox (Varicella) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Green Cross Recent Developments
    11.9 Biken
        11.9.1 Biken Corporation Information
        11.9.2 Biken Overview
        11.9.3 Biken Chickenpox (Varicella) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Biken Chickenpox (Varicella) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Biken Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Chickenpox (Varicella) Vaccine Industry Chain Analysis
    12.2 Chickenpox (Varicella) Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Chickenpox (Varicella) Vaccine Production Mode & Process
    12.4 Chickenpox (Varicella) Vaccine Sales and Marketing
        12.4.1 Chickenpox (Varicella) Vaccine Sales Channels
        12.4.2 Chickenpox (Varicella) Vaccine Distributors
    12.5 Chickenpox (Varicella) Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Chickenpox (Varicella) Vaccine Industry Trends
    13.2 Chickenpox (Varicella) Vaccine Market Drivers
    13.3 Chickenpox (Varicella) Vaccine Market Challenges
    13.4 Chickenpox (Varicella) Vaccine Market Restraints
14 Key Findings in The Global Chickenpox (Varicella) Vaccine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Chickenpox (Varicella) Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Monovalent Vaccine
    Table 3. Major Manufacturers of Combination Vaccine
    Table 4. Global Chickenpox (Varicella) Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Chickenpox (Varicella) Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Chickenpox (Varicella) Vaccine Sales by Region (2017-2022) & (K Doses)
    Table 7. Global Chickenpox (Varicella) Vaccine Sales Market Share by Region (2017-2022)
    Table 8. Global Chickenpox (Varicella) Vaccine Sales by Region (2023-2028) & (K Doses)
    Table 9. Global Chickenpox (Varicella) Vaccine Sales Market Share by Region (2023-2028)
    Table 10. Global Chickenpox (Varicella) Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Region (2017-2022)
    Table 12. Global Chickenpox (Varicella) Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Region (2023-2028)
    Table 14. Global Chickenpox (Varicella) Vaccine Sales by Manufacturers (2017-2022) & (K Doses)
    Table 15. Global Chickenpox (Varicella) Vaccine Sales Share by Manufacturers (2017-2022)
    Table 16. Global Chickenpox (Varicella) Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Chickenpox (Varicella) Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 18. Chickenpox (Varicella) Vaccine Price by Manufacturers (2017-2022) &(USD/dose)
    Table 19. Global Chickenpox (Varicella) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Chickenpox (Varicella) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chickenpox (Varicella) Vaccine as of 2021)
    Table 21. Chickenpox (Varicella) Vaccine Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Chickenpox (Varicella) Vaccine Product Offered
    Table 23. Date of Manufacturers Enter into Chickenpox (Varicella) Vaccine Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Chickenpox (Varicella) Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 26. Global Chickenpox (Varicella) Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 27. Global Chickenpox (Varicella) Vaccine Sales Share by Type (2017-2022)
    Table 28. Global Chickenpox (Varicella) Vaccine Sales Share by Type (2023-2028)
    Table 29. Global Chickenpox (Varicella) Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Chickenpox (Varicella) Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Chickenpox (Varicella) Vaccine Revenue Share by Type (2017-2022)
    Table 32. Global Chickenpox (Varicella) Vaccine Revenue Share by Type (2023-2028)
    Table 33. Chickenpox (Varicella) Vaccine Price by Type (2017-2022) & (USD/dose)
    Table 34. Global Chickenpox (Varicella) Vaccine Price Forecast by Type (2023-2028) & (USD/dose)
    Table 35. Global Chickenpox (Varicella) Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 36. Global Chickenpox (Varicella) Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 37. Global Chickenpox (Varicella) Vaccine Sales Share by Application (2017-2022)
    Table 38. Global Chickenpox (Varicella) Vaccine Sales Share by Application (2023-2028)
    Table 39. Global Chickenpox (Varicella) Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Chickenpox (Varicella) Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Chickenpox (Varicella) Vaccine Revenue Share by Application (2017-2022)
    Table 42. Global Chickenpox (Varicella) Vaccine Revenue Share by Application (2023-2028)
    Table 43. Chickenpox (Varicella) Vaccine Price by Application (2017-2022) & (USD/dose)
    Table 44. Global Chickenpox (Varicella) Vaccine Price Forecast by Application (2023-2028) & (USD/dose)
    Table 45. North America Chickenpox (Varicella) Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 46. North America Chickenpox (Varicella) Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 47. North America Chickenpox (Varicella) Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Chickenpox (Varicella) Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Chickenpox (Varicella) Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 50. North America Chickenpox (Varicella) Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 51. North America Chickenpox (Varicella) Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Chickenpox (Varicella) Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Chickenpox (Varicella) Vaccine Sales by Country (2017-2022) & (K Doses)
    Table 54. North America Chickenpox (Varicella) Vaccine Sales by Country (2023-2028) & (K Doses)
    Table 55. North America Chickenpox (Varicella) Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Chickenpox (Varicella) Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Chickenpox (Varicella) Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 58. Europe Chickenpox (Varicella) Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 59. Europe Chickenpox (Varicella) Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Chickenpox (Varicella) Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Chickenpox (Varicella) Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 62. Europe Chickenpox (Varicella) Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 63. Europe Chickenpox (Varicella) Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Chickenpox (Varicella) Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Chickenpox (Varicella) Vaccine Sales by Country (2017-2022) & (K Doses)
    Table 66. Europe Chickenpox (Varicella) Vaccine Sales by Country (2023-2028) & (K Doses)
    Table 67. Europe Chickenpox (Varicella) Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Chickenpox (Varicella) Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Chickenpox (Varicella) Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 70. Asia Pacific Chickenpox (Varicella) Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 71. Asia Pacific Chickenpox (Varicella) Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Chickenpox (Varicella) Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Chickenpox (Varicella) Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 74. Asia Pacific Chickenpox (Varicella) Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 75. Asia Pacific Chickenpox (Varicella) Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Chickenpox (Varicella) Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Chickenpox (Varicella) Vaccine Sales by Region (2017-2022) & (K Doses)
    Table 78. Asia Pacific Chickenpox (Varicella) Vaccine Sales by Region (2023-2028) & (K Doses)
    Table 79. Asia Pacific Chickenpox (Varicella) Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Chickenpox (Varicella) Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Chickenpox (Varicella) Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 82. Latin America Chickenpox (Varicella) Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 83. Latin America Chickenpox (Varicella) Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Chickenpox (Varicella) Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Chickenpox (Varicella) Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 86. Latin America Chickenpox (Varicella) Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 87. Latin America Chickenpox (Varicella) Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Chickenpox (Varicella) Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Chickenpox (Varicella) Vaccine Sales by Country (2017-2022) & (K Doses)
    Table 90. Latin America Chickenpox (Varicella) Vaccine Sales by Country (2023-2028) & (K Doses)
    Table 91. Latin America Chickenpox (Varicella) Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Chickenpox (Varicella) Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 94. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 95. Middle East and Africa Chickenpox (Varicella) Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Chickenpox (Varicella) Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 98. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 99. Middle East and Africa Chickenpox (Varicella) Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Chickenpox (Varicella) Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country (2017-2022) & (K Doses)
    Table 102. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country (2023-2028) & (K Doses)
    Table 103. Middle East and Africa Chickenpox (Varicella) Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Chickenpox (Varicella) Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Merck & Co. Corporation Information
    Table 106. Merck & Co. Description and Major Businesses
    Table 107. Merck & Co. Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2017-2022)
    Table 108. Merck & Co. Chickenpox (Varicella) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Merck & Co. Recent Developments
    Table 110. Sanofi Pasteur Corporation Information
    Table 111. Sanofi Pasteur Description and Major Businesses
    Table 112. Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2017-2022)
    Table 113. Sanofi Pasteur Chickenpox (Varicella) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Sanofi Pasteur Recent Developments
    Table 115. GSK Corporation Information
    Table 116. GSK Description and Major Businesses
    Table 117. GSK Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2017-2022)
    Table 118. GSK Chickenpox (Varicella) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. GSK Recent Developments
    Table 120. Shanghai Institute Corporation Information
    Table 121. Shanghai Institute Description and Major Businesses
    Table 122. Shanghai Institute Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2017-2022)
    Table 123. Shanghai Institute Chickenpox (Varicella) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Shanghai Institute Recent Developments
    Table 125. BCHT Corporation Information
    Table 126. BCHT Description and Major Businesses
    Table 127. BCHT Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2017-2022)
    Table 128. BCHT Chickenpox (Varicella) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. BCHT Recent Developments
    Table 130. Changsheng Corporation Information
    Table 131. Changsheng Description and Major Businesses
    Table 132. Changsheng Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2017-2022)
    Table 133. Changsheng Chickenpox (Varicella) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Changsheng Recent Developments
    Table 135. Keygen Corporation Information
    Table 136. Keygen Description and Major Businesses
    Table 137. Keygen Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2017-2022)
    Table 138. Keygen Chickenpox (Varicella) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Keygen Recent Developments
    Table 140. Green Cross Corporation Information
    Table 141. Green Cross Description and Major Businesses
    Table 142. Green Cross Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2017-2022)
    Table 143. Green Cross Chickenpox (Varicella) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Green Cross Recent Developments
    Table 145. Biken Corporation Information
    Table 146. Biken Description and Major Businesses
    Table 147. Biken Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2017-2022)
    Table 148. Biken Chickenpox (Varicella) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Biken Recent Developments
    Table 150. Key Raw Materials Lists
    Table 151. Raw Materials Key Suppliers Lists
    Table 152. Chickenpox (Varicella) Vaccine Distributors List
    Table 153. Chickenpox (Varicella) Vaccine Customers List
    Table 154. Chickenpox (Varicella) Vaccine Market Trends
    Table 155. Chickenpox (Varicella) Vaccine Market Drivers
    Table 156. Chickenpox (Varicella) Vaccine Market Challenges
    Table 157. Chickenpox (Varicella) Vaccine Market Restraints
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Chickenpox (Varicella) Vaccine Product Picture
    Figure 3. Global Chickenpox (Varicella) Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Monovalent Vaccine Product Picture
    Figure 4. Combination Vaccine Product Picture
    Figure 5. Global Chickenpox (Varicella) Vaccine Market Share by Application in 2021 & 2028
    Figure 6. Kids Injection
    Figure 7. Adults Injection
    Figure 8. Chickenpox (Varicella) Vaccine Report Years Considered
    Figure 9. Global Chickenpox (Varicella) Vaccine Sales 2017-2028 (K Doses)
    Figure 10. Global Chickenpox (Varicella) Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Chickenpox (Varicella) Vaccine Revenue 2017-2028 (US$ Million)
    Figure 12. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Chickenpox (Varicella) Vaccine Sales Market Share by Region (2017-2022)
    Figure 14. Global Chickenpox (Varicella) Vaccine Sales Market Share by Region (2023-2028)
    Figure 15. North America Chickenpox (Varicella) Vaccine Sales YoY (2017-2028) & (K Doses)
    Figure 16. North America Chickenpox (Varicella) Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Chickenpox (Varicella) Vaccine Sales YoY (2017-2028) & (K Doses)
    Figure 18. Europe Chickenpox (Varicella) Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Chickenpox (Varicella) Vaccine Sales YoY (2017-2028) & (K Doses)
    Figure 20. Asia-Pacific Chickenpox (Varicella) Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Chickenpox (Varicella) Vaccine Sales YoY (2017-2028) & (K Doses)
    Figure 22. Latin America Chickenpox (Varicella) Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Chickenpox (Varicella) Vaccine Sales YoY (2017-2028) & (K Doses)
    Figure 24. Middle East & Africa Chickenpox (Varicella) Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Chickenpox (Varicella) Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Chickenpox (Varicella) Vaccine in the World: Market Share by Chickenpox (Varicella) Vaccine Revenue in 2021
    Figure 27. Global Chickenpox (Varicella) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Chickenpox (Varicella) Vaccine Sales Market Share by Type (2017-2028)
    Figure 29. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2017-2028)
    Figure 30. Global Chickenpox (Varicella) Vaccine Sales Market Share by Application (2017-2028)
    Figure 31. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2017-2028)
    Figure 32. North America Chickenpox (Varicella) Vaccine Sales Market Share by Type (2017-2028)
    Figure 33. North America Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2017-2028)
    Figure 34. North America Chickenpox (Varicella) Vaccine Sales Market Share by Application (2017-2028)
    Figure 35. North America Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2017-2028)
    Figure 36. North America Chickenpox (Varicella) Vaccine Sales Share by Country (2017-2028)
    Figure 37. North America Chickenpox (Varicella) Vaccine Revenue Share by Country (2017-2028)
    Figure 38. the United States Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Chickenpox (Varicella) Vaccine Sales Market Share by Type (2017-2028)
    Figure 41. Europe Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Chickenpox (Varicella) Vaccine Sales Market Share by Application (2017-2028)
    Figure 43. Europe Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Chickenpox (Varicella) Vaccine Sales Share by Country (2017-2028)
    Figure 45. Europe Chickenpox (Varicella) Vaccine Revenue Share by Country (2017-2028)
    Figure 46. Germany Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 47. France Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 48. UK Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Chickenpox (Varicella) Vaccine Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Chickenpox (Varicella) Vaccine Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Chickenpox (Varicella) Vaccine Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Chickenpox (Varicella) Vaccine Revenue Share by Region (2017-2028)
    Figure 57. China Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 60. India Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 62. China Taiwan Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 66. Latin America Chickenpox (Varicella) Vaccine Sales Market Share by Type (2017-2028)
    Figure 67. Latin America Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2017-2028)
    Figure 68. Latin America Chickenpox (Varicella) Vaccine Sales Market Share by Application (2017-2028)
    Figure 69. Latin America Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2017-2028)
    Figure 70. Latin America Chickenpox (Varicella) Vaccine Sales Share by Country (2017-2028)
    Figure 71. Latin America Chickenpox (Varicella) Vaccine Revenue Share by Country (2017-2028)
    Figure 72. Mexico Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 73. Brazil Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 74. Argentina Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 75. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share by Type (2017-2028)
    Figure 76. Middle East and Africa Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share by Application (2017-2028)
    Figure 78. Middle East and Africa Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Share by Country (2017-2028)
    Figure 80. Middle East and Africa Chickenpox (Varicella) Vaccine Revenue Share by Country (2017-2028)
    Figure 81. Turkey Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 82. Saudi Arabia Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 83. UAE Chickenpox (Varicella) Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 84. Chickenpox (Varicella) Vaccine Value Chain
    Figure 85. Chickenpox (Varicella) Vaccine Production Process
    Figure 86. Channels of Distribution
    Figure 87. Distributors Profiles
    Figure 88. Bottom-up and Top-down Approaches for This Report
    Figure 89. Data Triangulation
    Figure 90. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck & Co.
Sanofi Pasteur
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
Frequently Asked Questions
Chickenpox (Varicella) Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Chickenpox (Varicella) Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Chickenpox (Varicella) Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Infusion Manifold

Infusion Manifold market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More

Wood Security Door

Wood Security Door market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More